Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2020
Nivolumab in Patients with Advanced Platinum-resistant Urothelial Carcinoma: Efficacy, Safety, and Biomarker Analyses with Extended Follow-up from CheckMate 275Matthew D Galsky, Abdel Saci, Peter M Szabo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2022
Meta-Analysis of the Test-Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor ResponseLalitha K Shankar, Erich Huang, Saskia Litiere, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trialsArjen Joosse, Sandra Collette, Stefan Suciu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trialsArjen Joosse, Sandra Collette, Stefan Suciu, et al.European Urology|August 6, 2013
Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCGMaurizio Brausi, Jorg Oddens, Richard Sylvester, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2015
Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trialIvalina Hristova, Ronald Boellaard, Wouter Vogel, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 20, 2013
Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trialsMukesh B Mukesh, Emma Harris, Sandra Collette, et al.JAMA Oncology|November 13, 2018
Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical TrialThomas M Churilla, Imran H Chowdhury, Elizabeth Handorf, et al.European Urology|November 13, 2012
Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenanceJorg Oddens, Maurizio Brausi, Richard Sylvester, et al.European Urology|December 28, 2010
A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinomaHendrik Van Poppel, Luigi Da Pozzo, Walter Albrecht, et al.Pageof 5